Dr. Christina Smolke

Money Moves

Leading the company's US manufacturing push

Antheia holds an $80 million conditional loan commitment from the Department of War's Office of Strategic Capital, announced October 17, to make drug ingredients in the US using engineered yeast. The country imports about 90% of the key starting materials and active pharmaceutical ingredients that go into generic medicines.

Updated Oct 23